News
Current position:Product Center > Cell lines > Cytokines > IL-6 > GP130 Reporter 293 Cell Line
GP130 Reporter 293 Cell Line
Description
Cat. No: GM-C39792
Product: GP130 Reporter 293 Cell Line


GP130 (glycoprotein 130), a key member of the IL-6 receptor family, is widely expressed on hematopoietic cells, hepatocytes, and tumor cells. By interacting with cytokines like IL-6 and IL-11, it activates signaling pathways such as JAK/STAT, MAPK/ERK, and PI3K/AKT to regulate immune responses, hematopoiesis, and metabolism. Physiologically, GP130 maintains immune homeostasis by promoting macrophage M2 polarization and inhibiting Th1/Th17 responses, while also participating in gluconeogenesis and lipid metabolism.

GP130 Reporter 293 Cell Line is a clonal stable HEK-293 cell line constructed using lentiviral technology, constitutive expression of the GP130 gene, along with signal-dependent expression of a luciferase reporter gene. The addition of the IL-6 and IL-6R complex binds to GP130 receptor, thereby activating downstream reporter genes and inducing luciferase expression. The luciferase readout represents the activation level of the signaling pathway and can thus be used for evaluating the in vitro effects of related drugs of this signal pathway.
Data
Response to Recombinant Protein. The GP130 Reporter 293 Cell Line (Cat. GM-C39792) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human IL-6/IL-6R (R&D/8954-SR), Human IL-6 (PeproTech/200-06), Human IL-6R (PeproTech/200-06RC) and a mixed solution of Human IL-6R and Human IL-6 in assay buffer (DMEM + 1% FBS + 1% P.S.) for 6 hours. Firefly luciferase activity was measured using the GM One-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold of Human IL-6/IL-6R was approximately [48.7]. Data are shown as drug mass concentration.
The passage stability of response to Recombinant Human IL-6/IL-6R alpha Protein. The passage 3, 13, and 23 of GP130 Reporter 293 Cell Line (Cat. GM-C39792) at a concentration of 1.5E4 cells/well (96-well format) were stimulated with serial dilutions of Recombinant Human IL-6/IL-6R alpha Protein (R&D/8954-SR) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
The passage stability of the GP130 Reporter 293 Cell Line (Cat. GM-C39792) was determined by flow cytometry using AIL6ST/gp130/CD130 Antibody (PE) (SinoBiological/10974-MM11-P).
Specifications
Cat. NoGM-C39792
ProductGP130 Reporter 293 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumDMEM+10% FBS+1% P.S
Growth mediumDMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+400 μg/mL G418
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
DMEMGibco/C11995500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
G418Genomeditech/GM-040402
Human IL-6 Recombinant ProteinPeproTech/200-06
Human IL-6R (soluble) Recombinant ProteinPeproTech/200-06RC
Recombinant Human IL-6/IL-6R alpha Protein ChimeraR&D/8954-SR
Anti-gp130/IL6ST Antibody (PE), Mouse MonoclonalSinoBiological/10974-MM11-P
GMOne-Step Luciferase Reporter Gene Assay KitGenomeditech/GM-040503
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+400 μg/mL G418

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Related Products
Get A Quote
Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current Position:Product Center > Cell lines > Cytokines > IL-6 > GP130 Reporter 293 Cell Line
classify
GP130 Reporter 293 Cell Line
Description
Cat. No: GM-C39792
Product: GP130 Reporter 293 Cell Line


GP130 (glycoprotein 130), a key member of the IL-6 receptor family, is widely expressed on hematopoietic cells, hepatocytes, and tumor cells. By interacting with cytokines like IL-6 and IL-11, it activates signaling pathways such as JAK/STAT, MAPK/ERK, and PI3K/AKT to regulate immune responses, hematopoiesis, and metabolism. Physiologically, GP130 maintains immune homeostasis by promoting macrophage M2 polarization and inhibiting Th1/Th17 responses, while also participating in gluconeogenesis and lipid metabolism.

GP130 Reporter 293 Cell Line is a clonal stable HEK-293 cell line constructed using lentiviral technology, constitutive expression of the GP130 gene, along with signal-dependent expression of a luciferase reporter gene. The addition of the IL-6 and IL-6R complex binds to GP130 receptor, thereby activating downstream reporter genes and inducing luciferase expression. The luciferase readout represents the activation level of the signaling pathway and can thus be used for evaluating the in vitro effects of related drugs of this signal pathway.
Data
Response to Recombinant Protein. The GP130 Reporter 293 Cell Line (Cat. GM-C39792) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human IL-6/IL-6R (R&D/8954-SR), Human IL-6 (PeproTech/200-06), Human IL-6R (PeproTech/200-06RC) and a mixed solution of Human IL-6R and Human IL-6 in assay buffer (DMEM + 1% FBS + 1% P.S.) for 6 hours. Firefly luciferase activity was measured using the GM One-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold of Human IL-6/IL-6R was approximately [48.7]. Data are shown as drug mass concentration.
The passage stability of response to Recombinant Human IL-6/IL-6R alpha Protein. The passage 3, 13, and 23 of GP130 Reporter 293 Cell Line (Cat. GM-C39792) at a concentration of 1.5E4 cells/well (96-well format) were stimulated with serial dilutions of Recombinant Human IL-6/IL-6R alpha Protein (R&D/8954-SR) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
The passage stability of the GP130 Reporter 293 Cell Line (Cat. GM-C39792) was determined by flow cytometry using AIL6ST/gp130/CD130 Antibody (PE) (SinoBiological/10974-MM11-P).
Specifications
Cat. NoGM-C39792
ProductGP130 Reporter 293 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumDMEM+10% FBS+1% P.S
Growth mediumDMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+400 μg/mL G418
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
DMEMGibco/C11995500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
BlasticidinGenomeditech/GM-040404
G418Genomeditech/GM-040402
Human IL-6 Recombinant ProteinPeproTech/200-06
Human IL-6R (soluble) Recombinant ProteinPeproTech/200-06RC
Recombinant Human IL-6/IL-6R alpha Protein ChimeraR&D/8954-SR
Anti-gp130/IL6ST Antibody (PE), Mouse MonoclonalSinoBiological/10974-MM11-P
GMOne-Step Luciferase Reporter Gene Assay KitGenomeditech/GM-040503
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin+400 μg/mL G418

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Related Products
Get A Quote
Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit